Literature DB >> 22565425

Onychomycosis: newer insights in pathogenesis and diagnosis.

Chander Grover1, Ananta Khurana.   

Abstract

Onychomycosis (OM) is the commonest disorder affecting the nail unit. The fact that it affects 3-26% people worldwide goes to show that it is a significant health problem. The prevalence of OM has been reported to be increasing over the years. Although, we know much about various predisposing factors, we are yet unclear about its exact pathogenesis. The peculiarities of the nail unit with respect to its structure and its immune mechanisms make OM an adversary, which once established is difficult to eradicate. There have been many recent advances in our understanding of the pathogenesis of OM and our methods of diagnosing it. The increasingly valuable role of histopathology; refinements in its technique; PCR techniques; Optical coherence tomography and advances in spectrometric techniques have been reported. The present review is aimed at discussing the newer advances in our understanding of the pathogenesis of various clinical types of OM apart from the newer and exciting techniques of diagnosing it.

Entities:  

Mesh:

Year:  2012        PMID: 22565425     DOI: 10.4103/0378-6323.95440

Source DB:  PubMed          Journal:  Indian J Dermatol Venereol Leprol        ISSN: 0378-6323            Impact factor:   2.545


  10 in total

1.  Onychomycosis Case Developing during Interferon Treatment.

Authors:  Nazan Tuna; Mustafa Teoman Erdem; Oğuz Karabay
Journal:  Balkan Med J       Date:  2013-03       Impact factor: 2.021

2.  Microemulsion-based antifungal gel delivery to nail for the treatment of onychomycosis: formulation, optimization, and efficacy studies.

Authors:  Bhavesh S Barot; Punit B Parejiya; Hetal K Patel; Dharmik M Mehta; Pragna K Shelat
Journal:  Drug Deliv Transl Res       Date:  2012-12       Impact factor: 4.617

3.  Genotyping and In Vitro Antifungal Susceptibility Testing of Fusarium Isolates from Onychomycosis in India.

Authors:  Chhavi Gupta; Marit Jongman; Shukla Das; K Snehaa; S N Bhattacharya; S Seyedmousavi; Anne D van Diepeningen
Journal:  Mycopathologia       Date:  2016-05-02       Impact factor: 2.574

4.  A case of onychomycosis caused by Aspergillus candidus.

Authors:  Bahram Ahmadi; Seyed Jamal Hashemi; Farideh Zaini; Mohammad Reza Shidfar; Maryam Moazeni; Bita Mousavi; Fatemeh Noorbakhsh; Mohsen Gheramishoar; Leila Hossein Pour; Sassan Rezaie
Journal:  Med Mycol Case Rep       Date:  2012-07-03

Review 5.  Nail Biopsy: A User's Manual.

Authors:  Chander Grover; Shikha Bansal
Journal:  Indian Dermatol Online J       Date:  2018 Jan-Feb

6.  Evaluation Of The Efficacy Of Fluorescent Staining And Chicago Sky Blue Staining As Methods For Diagnosis Of Dermatophytosis In Hair And Nails.

Authors:  Basma Mourad; Mayada Ismail; Soha Hawwam; Mina Msseha; Reham Hassan
Journal:  Clin Cosmet Investig Dermatol       Date:  2019-10-09

Review 7.  Onychomycosis: An Updated Review.

Authors:  Alexander K C Leung; Joseph M Lam; Kin F Leong; Kam L Hon; Benjamin Barankin; Amy A M Leung; Alex H C Wong
Journal:  Recent Pat Inflamm Allergy Drug Discov       Date:  2020

8.  Associations between onychomycosis and COVID-19 clinical outcomes: a retrospective cohort study from a US metropolitan center.

Authors:  Uros Rakita; Trisha Kaundinya; Armaan Guraya; Kamaria Nelson; Brittany Maner; Jaya Manjunath; Gabrielle Schwartzman; Brittany Lane; Jonathan I Silverberg
Journal:  Arch Dermatol Res       Date:  2021-11-12       Impact factor: 3.033

9.  Effective Single Photodynamic Treatment of ex Vivo Onychomycosis Using a Multifunctional Porphyrin Photosensitizer and Green Light.

Authors:  Chelsea den Hollander; Jasper Visser; Ellen de Haas; Luca Incrocci; Threes Smijs
Journal:  J Fungi (Basel)       Date:  2015-07-27

10.  Onychomycosis among Clinically Suspected Cases Attending the Dermatology Out-patient Department of a Tertiary Care Centre: A Descriptive Cross-sectional Study.

Authors:  Beena Jha; Manisha Sharma; Sagar Gc; Jyotshna Sapkota
Journal:  JNMA J Nepal Med Assoc       Date:  2021-05-25       Impact factor: 0.406

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.